FDA enforcement action will be swifter, with less notice

The FDA has put supplement companies on notice that violators can expect earlier detection and prosecution. The agency has shifted to a policy of less talk and more action. The industry response must be to get better or get out.

FDA joins those warning of steroid dangers

Several hours after our post on increased media coverage of the potential danger of supplement use by high school athletes, the Food & Drug Administration held a press conference and issued a public health advisory on body-building products and steroids. The warning was serious: “Due to the potentially serious health risks associated with using these types of products, the FDA recommends that consumers immediately stop using all body building products that claim to contain steroids or steroid-like substances, ” the FDA said in the advisory.